Taken together, our findings suggest a potential pathogenic role of CR Abs in exacerbating COVID-19 by promoting NETosis, highlighting ACE2 and dasatinib as potential treatments and emphasizing the importance of vaccination in reducing CR Abs production. This evidence concerns the gene ACE2 and COVID-19.